Tag: CB2 Insights
April 20, 2020
CB2 Insights Completes Purchase of Colorado-based Relaxed Clarity with Surpassed Initial Targets and Provides Additional Corporate Updates
CB2 Insights (CSE:CBII; OTCQB: CBIIF) has completed the terms of the purchase agreement of Colorado-based Rae of Sunshine Health Services. April 15, 2020
CB2 Insights Announces Delay in Filing Under CSA Instrument Governing Relief Under COVID-19 Duress
CB2 Insights (CSE:CBII), has announced that due to circumstances created by the COVID – 19 pandemic, it will not be... March 30, 2020
CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders
Free interactive tool allows industry players to gain immediate insights derived from CB2 Insights aggregated and anonymized clinical outcome data. January 29, 2020
CB2 Insights Appoints Healthcare Industry Expert and Former IQVIA Executive Tom Brogan to its Board of Directors
CB2 Insights is pleased to announce the appointment of Tom Brogan, as an independent director to CB2’s Board of Directors. January 28, 2020
CB2 Insights Announces Completion of Payment of New Jersey Alternative Medicine
CB2 Insights announces it has completed all payment obligations for the June 2019 acquisition of New Jersey Alternative Medicine. January 14, 2020
CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial
Partnership Underway to Develop Extensive Protocols and Submissions for US Food & Drug Administration to Uncover Safety and Efficacy for... December 16, 2019